How do you approach the outpatient management of bispecific antibody therapy for hematologic malignancies?
1 Answers
Mednet Member
Medical Oncology · Harvard Medical School
Multiple bispecific antibodies (BsAbs) targeting CD20 on lymphoma cells and CD3 on T-cells are now available in follicular and large B-cell lymphoma. A multi-disciplinary team with knowledge of the different BsAb indications and possible toxicities is an important aspect of safely administering thes...